Key Features and Values

– Same sample type can be used across all assays to simplify inclusion into routine serology work-up
– Ready to use reagents reduces hands-on time for assay preparation
– Long shelf life provides a cost-effective solution by reducing wastage due to expired kits
– Suitable for inclusion on automated plate systems simplifies scale-up of test volume
– Supported by a complete panel of assays for supporting treatment monitoring of several forms of hormonal dysfunctions
– Suitable for use in a wide range of areas including sports medicine, paediatrics, occupational health, veterinary medicine, sleep disturbance, stress monitoring and hormone replacement therapy

Product Description

Competitive immunoenzymatic colorimetric method for quantitative determination of DHEA-S concentration in saliva.  DHEA-S Saliva ELISA kit is intended for laboratory use only.

Scientific Description
5-Dehydroepiandrosterone (DHEA-5) is an endogenous natural steroid hormone with 19 carbon atoms.  It is the principal steroid hormone produced by the secretion of the adrenal glands, but it is also produced in the gonads and brain.  DHEA is the most abundant circulating steroid in human beings.
DHEA-S is a natural steroid hormone found primarily in the kidneys and it is derived from the enzymatic conversion of DHEA in the adrenal and extra-adrenal tissues.  It is the most abundant hormone in the human body and is a precursor of all sex steroids.  As most DHEA-S is produced by the zona reticularis of the adrenal, it is argued that there is a role in the immune and stress response.  DHEA-S may have more biologic roles: for example its production in the brain suggests a role as neurosteroid.
The majority of DHEA-S in saliva is non-protein bound and enters the saliva via intracellular mechanisms.  Salivary DHEA-S levels are unaffected by salivary flow rate or salivary enzymes. Measurement of serum DHEA-S is a useful marker of adrenal androgen synthesis.  Abnormally low levels may occur in have been reported in hypoadrenalism, while elevated levels occur in several conditions, e.g. virilising adrenal adenoma and carcinoma, 21-hydroxylase and 3β-hydroxysteroid dehydrogenase deficiencies and in some cases of female hirsutism.
Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEAS.

1. Joshi, U. M., et al. Steroids 34 (1) 35 (1979)
2. Turkes, A., et al. J Endocrinol. 81 (2) P165 (1979)
3. Ismail A.A, et al. J.Clin.Endocr.Metab. 34,177-184 (1972)
4. Rajkowski,K.M, et al. Steroids 29 no 5 (1977)
5. Widsdom G.B. Clin. Chem. 22/8, 1243 – 1255 (1976)
6. Abraham G.E, et al. Obstet.Gynecol.,47(4),395 (1976)
7. Abraham G.E, et al. Obstet. Gynecol.,53(1),111 (1979)
8. Hopper B.R, et al. J.Clin.Endoc.Metab.40(3),458 (1975)
9. Winter J.S.D,et al. Clin.Obste.and Gynec.,21(1),67 (1978)
10. D. Riad et al. Endocr. Reviews, 3 (4) 304 367 (1978)


Please enter your email address to download
Code: DKO024
Clinical Area:
Incubation: 15+15 min
Sensitivity: N/A
Specificity: N/A
Classification: IVD, CE
Number of Tests: 96
Sample Type: Saliva
Sample Volume: 15 μL
Assay Range: 0,2 - 12 ng/mL